Nautilus Biotechnology, Inc.
NAUT
$2.35
$0.020.86%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 11.53% | 21.67% | 17.46% | 16.53% | 11.30% |
| Total Depreciation and Amortization | -9.17% | -2.99% | 0.43% | 2.25% | 2.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -20.47% | -58.94% | -51.65% | -50.72% | -31.15% |
| Change in Net Operating Assets | -103.65% | 5.53% | 63.65% | 24.74% | 61.34% |
| Cash from Operations | 6.01% | 13.52% | 15.85% | 13.63% | 14.32% |
| Capital Expenditure | -132.88% | 75.94% | 41.04% | 22.66% | 66.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -25.28% | -97.30% | 112.81% | 0.43% | -14.22% |
| Cash from Investing | -27.05% | -97.88% | 106.02% | 1.26% | -12.71% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6,038.89% | -77.05% | -100.00% | -70.22% | -92.65% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6,038.89% | -77.05% | -100.00% | -70.22% | -92.65% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -59.98% | -149.43% | 48.32% | 244.43% | -11.69% |